In The News Posted November 9, 2019 Share Posted November 9, 2019 ZHONGSHAN, China, Nov. 9, 2019 /PRNewswire/ -- Akeso,Inc. (hereinafter referred to as "Akeso"), a Chinese biopharmaceutical company focusing on new innovative antibody drug discovery and development in oncology and immunology therapeutic areas, announced the completion of its Series-D... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.